Krystal Biotech
KRYS
#2707
Rank
โ‚ฌ4.22 B
Marketcap
146,19ย โ‚ฌ
Share price
-1.78%
Change (1 day)
-3.43%
Change (1 year)

P/E ratio for Krystal Biotech (KRYS)

P/E ratio as of April 2025 (TTM): -30.5

According to Krystal Biotech's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -30.5341. At the end of 2022 the company had a P/E ratio of -14.4.

P/E ratio history for Krystal Biotech from 2017 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-14.4-35.67%
2021-22.3-36.68%
2020-35.3-22.25%
2019-45.4111.89%
2018-21.4225.43%
2017-6.58

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-2.37-92.23%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.